52 Week Low is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period. $ 85.83 / $ 41.57. Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent.
http://www.nasdaq.com/symbol/mnk
For nearly 150 years, we have strived to make quality products that offer immense value to the healthcare we jointly serve. Our future-focused vision and dedication to improving lives are matched only by our distinctive approach to managing the complex.
https://www.mallinckrodt.com/
Seeing opportunity for shareholders. In 2014, Mallinckrodt was one of the leading performers of the S&P 500, reporting fiscal year revenues of $2.54 billion, and we are continuing our transformation to a top-performing specialty biopharmaceutical company.
https://www.mallinckrodt.com/
Trades from $3. Mallinckrodt’s (MNK - Free Report) shares inched up 1.1% after the company announced the completion of its acquisition of Questcor Pharmaceuticals, Inc. in a deal valued at approximately $5.8 billion. Meanwhile, Mallinckrodt is also set to join the S&P 500 after market closes on Aug 18. Mallinckrodt-Questcor Transaction.
https://www.zacks.com/stock/news/144193/mallinckrodt-acquires-questcor-to-join-sampp-500-as-well
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an uptick in price and the value of trades made on a downtick in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades.
http://quotes.wsj.com/MNK
Profits were good … perhaps even great. Mallinckrodt earned $2.04 per share on sales of $887.2 million, versus estimates for a profit of $1.98 per share of MNK and revenue of $862 million.
http://investorplace.com/2016/11/why-mallinckrodt-plc-mnk-vale-sa-adr-vale-and-marathon-oil-corporation-mro-are-3-of-todays-worst-stocks/
Mallinckrodt Begins Trading on NYSE. Spinoff from medical-device maker Covidien was completed on June 28. With the spinoff complete from Covidien (NYSE:COV) effective June 28, the medical device manufacturer's former specialty pharmaceutical arm, Mallinckrodt, begins its new life today as an independently traded public company.
https://www.fool.com/investing/general/2013/07/01/mallinckrodt-begins-trading-on-nyse.aspx
Covidien to spin off Mallinckrodt on June 28. Covidien plc said Friday that it plans to spin off its $2 billion Hazelwood-based pharmaceutical business as an independent company after the close of stock trading on June 28. The move will restore the historic name of Mallinckrodt to an independent local company.
http://www.stltoday.com/business/local/covidien-to-spin-off-mallinckrodt-on-june/article_90f0f0c6-c33a-51cd-8285-80bc564ad6ef.html
The S&P 500‘s close of 2,204.66 was 0.13% stronger than Monday’s close. It wasn’t a winning session for all stocks, however. Marathon Oil Corporation (NYSE:MRO), Mallinckrodt PLC (NYSE:MNK) and Vale SA (ADR) (NYSE:VALE) each took big hits.
http://investorplace.com/2016/11/why-mallinckrodt-plc-mnk-vale-sa-adr-vale-and-marathon-oil-corporation-mro-are-3-of-todays-worst-stocks/
Spinoff from medical-device maker Covidien was completed on June 28. Jul 1, 2013 at 5:20PM. With the spinoff complete from Covidien (NYSE:COV) effective June 28, the medical device manufacturer's former specialty pharmaceutical arm, Mallinckrodt, begins its new life today as an independently traded public company.
https://www.fool.com/investing/general/2013/07/01/mallinckrodt-begins-trading-on-nyse.aspx
when did mallinckrodt start trading
Mallinckrodt started trading on June 28.